Pharmacotherapy of Insomnia with Ramelteon: Safety, Efficacy and Clinical Applications

Ramelteon is a tricyclic synthetic analog of melatonin that acts specifically on MT(1) and MT(2) melatonin receptors. Ramelteon is the first melatonin receptor agonist approved by the Food and Drug Administration (FDA) for the treatment of insomnia characterized by sleep onset difficulties. Ramelteo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Pandi-Perumal, Seithikurippu R., Spence, D. Warren, Verster, Joris C., Srinivasan, Venkatramanujam, Brown, Gregory M., Cardinali, Daniel P., Hardeland, Rüdiger
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Libertas Academica 2011
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3663615/
https://ncbi.nlm.nih.gov/pubmed/23861638
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/JCNSD.S1611
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak